|
References
| | 1. |  | Dahlquist GG. Primary and secondary prevention strategies of pre-type 1 diabetes. Potentials and pitfalls. Diabetes Care. 1999;22 Suppl 2:B4-6. (PMID: 10097892) | | 2. |  | Srikanta S, Ganda OP, Jackson RA, Gleason RE, Kaldany A, Garovoy MR, et al. Type 1 diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med. 1983;99:320-6. (PMID: 6351687) | | 3. | | Srikanta S, Ganda OP, Eisenbarth GS, Soeldner JS. Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type 1 diabetes mellitus. N Engl J Med. 1983;308:322-5. (PMID: 6337325) | | 4. | | Sosenko JM, Krischer JP, Palmer JP, Mahon J, Cowie C, Greenbaum CJ, et al. A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1. Diabetes Care. 2008;31:528-33. (PMID: 18000175) | | 5. | | Faich GA, Fishbein HA, Ellis SE. The epidemiology of diabetic acidosis: a population-based study. Am J Epidemiol. 1983;117:551-8. (PMID: 6405612) | | 6. | | Johnson DD, Palumbo PJ, Chu CP. Diabetic ketoacidosis in a community-based population. Mayo Clin Proc. 1980;55:83-8. (PMID: 6766521) | | 7. | | Vanelli M, Chiari G, Ghizzoni L, Costi G, Giacalone T, Chiarelli F. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care. 1999;22:7-9. (PMID: 10333896) | | 8. |  | Eisenbarth GS, Connelly J, Soeldner JS. The “natural” history of type 1 diabetes. Diabetes Metab Rev. 1987;3:873-91. (PMID: 3315524) | | 9. | | Dyrberg T, Benn J, Christiansen JS, Hilsted J, Nerup J. Prevalence of diabetic autonomic neuropathy measured by simple bedside tests. Diabetologia. 1981;20:190-4. (PMID: 7227699) | | 10. | | Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med. 1980;49:95-108. (PMID: 7433630) | | 11. | | Ziegler D, Mayer P, Mühlen H, Gries FA. The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1991;34:822-9. (PMID: 1769441) | | 12. | | O’Brien IA, McFadden JP, Corrall RJ. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med. 1991;79:495-502. (PMID: 1946930) | | 13. | | Kaiser FE, Korenman SG. Impotence in diabetic men. Am J Med. 1988;85:147-52. (PMID: 2904224) | | 14. | | McCulloch DK, Campbell IW, Wu FC, Prescott RJ, Clarke BF. The prevalence of diabetic impotence. Diabetologia. 1980;18:279-83. (PMID: 7418954) | | 15. | | Bradley WE. Aspects of diabetic autonomic neuropathy. Introduction and workshop summary. Ann Intern Med. 1980;92:293-6. (PMID: 7356217) | | 16. | | Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med. 2005;352:2598-608. (PMID: 15972866) | | 17. | | Leshin M. Polyglandular autoimmune syndromes. Am J Med Sci. 1985;290:77-88. (PMID: 3898841) | | 18. | | Mouradian M, Abourizk N. Diabetes mellitus and thyroid disease. Diabetes Care. 1983;6:512-20. (PMID: 6400713) | | 19. | | Riley WJ, Maclaren NK, Lezotte DC, Spillar RP, Rosenbloom AL. Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. J Pediatr. 1981;99:350-4. (PMID: 7264787) | | 20. | | Franz MJ, Horton ES Sr, Bantle JP, Beebe CA, Brunzell JD, Coulston AM, et al. Nutrition principles for the management of diabetes and related complications. Diabetes Care. 1994;17:490-518. (PMID: 8062628) | | 21. | | Rosenbloom AL, Silverstein JH. Connective tissue and joint disease in diabetes mellitus. Endocrinol Metab Clin North Am. 1996;25:473-83. (PMID: 8799711) | | 22. | | Bailey TS, Yu HM, Rayfield EJ. Patterns of foot exam in a diabetes clinic. Am J Med. 1985;78:371-4. (PMID: 3976699) | | 23. | | Wylie-Rosett J, Walker EA, Shamoon H, Engel S, Basch C, Zybert P. Assessment of documented foot exams for patients with diabetes in inner-city primary care clinics. Arch Fam Med. 1995;4:46-50. (PMID: 7812476) | | 24. | | Rith-Najarian SJ, Stolusky T, Gohdes DM. Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria. Diabetes Care. 1992;15:1386-9. (PMID: 1425105) | | 25. | | The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977-86. (PMID: 8366922) | | 26. | | Pietri A, Dunn FL, Raskin P. The effect of improved diabetic control on plasma lipid and lipoprotein levels: a comparison of conventional therapy and continuous subcutaneous insulin infusion. Diabetes. 1980;29:1001-5. (PMID: 7002668) | | 27. | | Smithson MJ. Screening for thyroid dysfunction in a community population of diabetic patients. Diabet Med. 1998;15:148-50. (PMID: 9507916) | | 28. | | Perros P, McCrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med. 1995;12:622-7. (PMID: 7554786) | | 29. | | Gray RS, Borsey DQ, Seth J, Herd R, Brown NS, Clarke BF. Prevalence of subclinical thyroid failure in insulin-dependent diabetes. J Clin Endocrinol Metab. 1980;50:1034-7. (PMID: 7372784) | | 30. | | Banerji MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, Mackay IR, et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes. 1994;43:741-5. (PMID: 8194658) | | 31. | | Winter WE, Nakamura M, House DV. Monogenic diabetes mellitus in youth. The MODY syndromes. Endocrinol Metab Clin North Am. 1999;28:765-85. (PMID: 10609119) | | 32. | | Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med. 1994;11:299-303. (PMID: 8033530) | | 33. | | Banerji MA, Chaiken RL, Lebovitz HE. Long-term normoglycemic remission in black newly diagnosed NIDDM subjects. Diabetes. 1996;45:337-41. (PMID: 8593939) | | 34. | | Furuta H, Iwasaki N, Oda N, Hinokio Y, Horikawa Y, Yamagata K, et al. Organization and partial sequence of the hepatocyte nuclear factor-4 alpha/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY. Diabetes. 1997;46:1652-7. (PMID: 9313765) | | 35. | | Yki-Järvinen H. MODY genes and mutations in hepatocyte nuclear factors. Lancet. 1997;349:516-7. (PMID: 9048783) | | 36. | | Zimmet P, Turner R, McCarty D, Rowley M, Mackay I. Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes. Diabetes Care. 1999;22 Suppl 2:B59-64. (PMID: 10097901) | | 37. | | Kitabchi AE, Fisher JN, Murphy MB, Rumbak MJ. Diabetic ketoacidosis and the hyperglycemic hypersomolar nonketotic state. In: Kahn CR, Weir GC, eds. Joslin's Diabetes Mellitus. 13th ed. Philadelphia: Lea & Febiger; 1994:740. | | 38. | | Glaser N, Barnett P, McCaslin I, Nelson D, Trainor J, Louie J, et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med. 2001;344:264-9. (PMID: 11172153) | | 39. | | Levetan CS, Passaro MD, Jablonski KA, Ratner RE. Effect of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care. 1999;22:1790-5. (PMID: 10546009) | | 40. | | Fishbein H, Palumbo PJ. Acute metabolic complications in diabetes. In: Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995:283-291. | | 41. | | Wetterhall SF, Olson DR, DeStefano F, Stevenson JM, Ford ES, German RR, et al. Trends in diabetes and diabetic complications, 1980-1987. Diabetes Care. 1992;15:960-7. (PMID: 1324144) | | 42. | | Holman RC, Herron CA, Sinnock P. Epidemiologic characteristics of mortality from diabetes with acidosis or coma, United States, 1970-78. Am J Public Health. 1983;73:1169-73. (PMID: 6412575) | | 43. | | Centers for Disease Control. Diabetes Control Projects, Phase 1, 1978. Assessment summary; June 1979. | | 44. | | Kitabchi AE, Rumbak MJ. Diabetic ketoacidosis: diagnosis, diabetic ketoacidosis, treatment, hyperglycemic hyperosmolar nonketotic coma, and maintenance treatment after hyperglycemic crisis. In: Callaham ML, Barton CW, Schumaker HM, eds. Decision Making in Emergency Medicine. Philadelphia: BC Decker; 1990:178-185. | | 45. | | Ennis D, Kreisberg RA. Diabetic ketoacidosis and the hyperglycemic hyperosmolar syndrome. In: LeRoith D, Taylor SI, Olefsky JM, eds. Diabetes Mellitus: A Fundamental and Clinical Text. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2000. | | 46. | | Ennis ED, Stahl Ej, Kreisberg RA. Diabetic ketoacidosis. In: Porte D, Sherwin RS, eds. Ellenberg and Rifkin's Diabetes Mellitus. 5th ed. Stamford, CT: Appleton & Lange; 1997. | | 47. | | Bischoff LG, Warzak WJ, Maguire KB, Corley KP. Acute and chronic effects of hypoglycemia on cognitive and psychomotor performance. Nebr Med J. 1992;77:253-62. (PMID: 1407220) | | 48. | | Deary IJ, Crawford JR, Hepburn DA, Langan SJ, Blackmore LM, Frier BM. Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes. 1993;42:341-4. (PMID: 8425671) | | 49. | | Wredling R, Levander S, Adamson U, Lins PE. Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man. Diabetologia. 1990;33:152-7. (PMID: 2184066) | | 50. | | Ratner RE, Whitehouse FW. Motor vehicles, hypoglycemia, and diabetic drivers. Diabetes Care. 1989;12:217-22. (PMID: 2649331) | | 51. | | Songer TJ, LaPorte RE, Dorman JS, Orchard TJ, Cruickshanks KJ, Becker DJ, et al. Motor vehicle accidents and IDDM. Diabetes Care. 1988;11:701-7. (PMID: 3224540) | | 52. | | Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999;22:1408-14. (PMID: 10480501) | | 53. | | Malmberg K, Norhammar A, Wedel H, Rydén L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation. 1999;99:2626-32. (PMID: 10338454) | | 54. | | Schade DS. Surgery and diabetes. Med Clin North Am. 1988;72:1531-43. (PMID: 3054366) | | 55. | | Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109:1497-502. (PMID: 15006999) | | 56. | | Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med. 1997;157:545-52. (PMID: 9066459) | | 57. | | Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramati N, Friedman AC, et al. Radiocontrast-associated renal dysfunction: incidence and risk factors. AJR Am J Roentgenol. 1991;157:49-58. (PMID: 2048539) | | 58. | | Stevens MA, McCullough PA, Tobin KJ, Speck JP, Westveer DC, Guido-Allen DA, et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Coll Cardiol. 1999;33:403-11. (PMID: 9973020) | | 59. | | Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int. 1994;45:259-65. (PMID: 8127017) | | 60. | | Delahanty LM, Halford BN. The role of diet behaviors in achieving improved glycemic control in intensively treated patients in the Diabetes Control and Complications Trial. Diabetes Care. 1993;16:1453-8. (PMID: 8299434) | | 61. | | Franz MJ, Monk A, Barry B, McClain K, Weaver T, Cooper N, et al. Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: a randomized, controlled clinical trial. J Am Diet Assoc. 1995;95:1009-17. (PMID: 7657902) | | 62. | | Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med. 1996;124:627-32. (PMID: 8607590) [Full Text] | | 63. | | Jibani MM, Bloodworth LL, Foden E, Griffiths KD, Galpin OP. Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: effects on albumin excretion rate and nutritional status. Diabet Med. 1991;8:949-53. (PMID: 1838047) | | 64. | | Milne RM, Mann JI, Chisholm AW, Williams SM. Long-term comparison of three dietary prescriptions in the treatment of NIDDM. Diabetes Care. 1994;17:74-80. (PMID: 8112194) | | 65. | | Horton ES. Role and management of exercise in diabetes mellitus. Diabetes Care. 1988;11:201-11. (PMID: 3289869) | | 66. | | Schneider SH, Vitug A, Ruderman N. Atherosclerosis and physical activity. Diabetes Metab Rev. 1986;1:513-53. (PMID: 3522141) | | 67. | | Wasserman DH, Zinman B. Exercise in individuals with IDDM. Diabetes Care. 1994;17:924-37. (PMID: 7956645) | | 68. | | Mitchell TH, Abraham G, Schiffrin A, Leiter LA, Marliss EB. Hyperglycemia after intense exercise in IDDM subjects during continuous subcutaneous insulin infusion. Diabetes Care. 1988;11:311-7. (PMID: 3042306) | | 69. | | Schneider SH, Kanj H. Clinical aspects of exercise and diabetes mellitus. Curr Concepts Nutr. 1986;15:145-82. (PMID: 3095032) | | 70. | | Haire-Joshu D, Glasgow RE, Tibbs TL. Smoking and diabetes. Diabetes Care. 1999;22:1887-98. (PMID: 10546025) | | 71. | | Chase HP, Garg SK, Marshall G, Berg CL, Harris S, Jackson WE, et al. Cigarette smoking increases the risk of albuminuria among subjects with type 1 diabetes. JAMA. 1991;265:614-7. (PMID: 1987411) | | 72. | | Mitchell BD, Hawthorne VM, Vinik AI. Cigarette smoking and neuropathy in diabetic patients. Diabetes Care. 1990;13:434-7. (PMID: 2318103) | | 73. | | Mühlhauser I, Bender R, Bott U, Jörgens V, Grüsser M, Wagener W, et al. Cigarette smoking and progression of retinopathy and nephropathy in type 1 diabetes. Diabet Med. 1996;13:536-43. (PMID: 8799657) | | 74. | | Klein R, Klein BE, Neider MW, Hubbard LD, Meuer SM, Brothers RJ. Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. Ophthalmology. 1985;92:485-91. (PMID: 4000642) | | 75. | | Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, et al. Retinopathy in diabetes. Diabetes Care. 2004;27 Suppl 1:S84-7. (PMID: 14693935) | | 76. | | Sussman EJ, Tsiaras WG, Soper KA. Diagnosis of diabetic eye disease. JAMA. 1982;247:3231-4. (PMID: 7087063) | | 77. | | Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med. 1989;149:2427-32. (PMID: 2684072) | | 78. | | Chew EY, Klein ML, Ferris FL III, Remaley NA, Murphy RP, Chantry K, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol. 1996;114:1079-84. (PMID: 8790092) | | 79. | | Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study Report no. 4. The Early Treatment Diabetic Retinopathy Study Research Group. Int Ophthalmol Clin. 1987;27:265-72. (PMID: 3692708) | | 80. | | Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. Ophthalmology. 1978;85:82-106. (PMID: 345173) | | 81. | | Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol. 1985;103:1796-806. (PMID: 2866759) | | 82. | | Morgado PB, Chen HC, Patel V, Herbert L, Kohner EM. The acute effect of smoking on retinal blood flow in subjects with and without diabetes. Ophthalmology. 1994;101:1220-6. (PMID: 8035985) | | 83. | | Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care. 1990;13:513-21. (PMID: 2351029) | | 84. | | Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputation in patients with diabetes mellitus. A case-control study. Ann Intern Med. 1992;117:97-105. (PMID: 1605439) | | 85. | | Dargis V, Pantelejeva O, Jonushaite A, Vileikyte L, Boulton AJ. Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care. 1999;22:1428-31. (PMID: 10480504) | | 86. | | Ragnarson-Tennvall G, Apelqvist J. Cost-effective management of diabetic foot ulcers. A review. Pharmacoeconomics. 1997;12:42-53. (PMID: 10173073) | | 87. | | Consensus Development Conference on Diabetic Foot Wound Care: 7-8 April 1999, Boston, Massachusetts. American Diabetes Association. Diabetes Care. 1999;22:1354-60. (PMID: 10480782) | | 88. | | The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes. 1996;45:1289-98. (PMID: 8826962) | | 89. | | Cryer PE, Fisher JN, Shamoon H. Hypoglycemia. Diabetes Care. 1994;17:734-55. (PMID: 7924788) | | 90. | | Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group. Am J Med. 1991;90:450-9. (PMID: 2012085) | | 91. | | Cryer PE. Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDM. Diabetes. 1994;43:1378-89. (PMID: 7926315) | | 92. | | de Boer IH, Kestenbaum B, Rue TC, Steffes MW, Cleary PA, Molitch ME, et al. Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus. Arch Intern Med. 2008;168:1867-73. (PMID: 18809813) | | 93. | | Skyler JS. Tactics for type 1 diabetes. Endocrinol Metab Clin North Am. 1997;26:647-57. (PMID: 9314020) | | 94. | | DeWitt DE, Hirsch IB. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA. 2003;289:2254-64. (PMID: 12734137) | | 95. | | Lev-Ran A. Clinical observation on brittle diabetes. Arch Intern Med. 1978;138:372-6. (PMID: 629631) | | 96. | | Saudek CD. Novel forms of insulin delivery. Endocrinol Metab Clin North Am. 1997;26:599-610. (PMID: 9314017) | | 97. | | White NH, Skor DA, Cryer PE, Levandoski LA, Bier DM, Santiago JV. Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med. 1983;308:485-91. (PMID: 6337335) | | 98. | | Amiel SA, Pottinger RC, Archibald HR, Chusney G, Cunnah DT, Prior PF, et al. Effect of antecedent glucose control on cerebral function during hypoglycemia. Diabetes Care. 1991;14:109-18. (PMID: 2060412) | | 99. | | Kinsley BT, Weinger K, Bajaj M, Levy CJ, Simonson DC, Quigley M, et al. Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes. Diabetes Care. 1999;22:1022-8. (PMID: 10388961) | | 100. | | Cox D, Gonder-Frederick L, Polonsky W, Schlundt D, Julian D, Clarke W. A multicenter evaluation of blood glucose awareness training-II. Diabetes Care. 1995;18:523-8. (PMID: 7497863) | | 101. | | Reviriego J, Gomis R, Marañés JP, Ricart W, Hudson P, Sacristán JA. Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia. Int J Clin Pract. 2008;62:1026-32. (PMID: 18489577) | | 102. | | Colwell JA. Aspirin therapy in diabetes. Diabetes Care. 1997;20:1767-71. (PMID: 9353620) | | 103. | | Collaborative overview of randomised trials of antiplatelet therapy–I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ. 1994;308:81-106. (PMID: 8298418) | | 104. | | Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med. 1989;321:129-35. (PMID: 2664509) | | 105. | | The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-46. (PMID: 9385294) | | 106. | | Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993;329:1456-62. (PMID: 8413456) | | 107. | | Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317:703-13. (PMID: 9732337) | | 108. | | Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279:1615-22. (PMID: 9613910) | | 109. | | Collins R, Armitage J, Parish S, Sleigh P, Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003;361:2005-16. (PMID: 12814710) | | 110. | | Koskinen P, Mänttäri M, Manninen V, Huttunen JK, Heinonen OP, Frick MH. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care. 1992;15:820-5. (PMID: 1516498) | | 111. | | Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987;317:1237-45. (PMID: 3313041) | | 112. | | Pyorälä K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care. 1997;20:614-20. (PMID: 9096989) | | 113. | | Goldberg RB, Mellies MJ, Sacks FM, Moyé LA, Howard BV, Howard WJ, et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. Circulation. 1998;98:2513-9. (PMID: 9843456) | | 114. | | Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996;335:1001-9. (PMID: 8801446) | | 115. | | Nelson RG, Knowler WC, Pettitt DJ, Bennett PH. Kidney diseases in diabetes. In: Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995:349-385. | | 116. | | Viberti GC, Jarrett RJ, Keen H. Microalbuminuria as prediction of nephropathy in diabetics. [Letter] Lancet. 1982;2:611. (PMID: 6125757) | | 117. | | Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984;311:89-93. (PMID: 6738599) | | 118. | | Lewis JB, Berl T, Bain RP, Rohde RD, Lewis EJ. Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group. Am J Kidney Dis. 1999;34:809-17. (PMID: 10561135) | | 119. | | Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007:CD005454. (PMID: 17943857) | | 120. | | Dworkin RH, O’Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132:237-51. (PMID: 17920770) | | 121. | | Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care. 1994;17:557-60. (PMID: 8082524) | | 122. | | McNeely MJ, Boyko EJ, Ahroni JH, Stensel VL, Reiber GE, Smith DG, et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks? Diabetes Care. 1995;18:216-9. (PMID: 7729300) | | 123. | | Wong MC, Chung JW, Wong TK. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ. 2007;335:87. (PMID: 17562735) | | 124. | | Miettinen H, Lehto S, Salomaa V, Mähönen M, Niemelä M, Haffner SM, et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care. 1998;21:69-75. (PMID: 9538972) | | 125. | | Rytter L, Troelsen S, Beck-Nielsen H. Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care. 1985;8:230-4. (PMID: 4006657) | | 126. | | Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes. 1974;23:105-11. (PMID: 4359625) | | 127. | | Yudkin JS. Managing the diabetic patient with acute myocardial infarction. Diabet Med. 1998;15:276-81. (PMID: 9585391) | | 128. | | Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med. 1996;335:217-25. (PMID: 8657237) | | 129. | | Bruno A, Kent TA, Coull BM, Shankar RR, Saha C, Becker KJ, et al. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke. 2008;39:384-9. (PMID: 18096840) | | 130. | | McCallum RW, Cynshi O; Investigative Team. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study. Aliment Pharmacol Ther. 2007;26:1121-30. (PMID: 17894654) | | 131. | | Feldman M, Smith HJ. Effect of cisapride on gastric emptying of indigestible solids in patients with gastroparesis diabeticorum. A comparison with metoclopramide and placebo. Gastroenterology. 1987;92:171-4. (PMID: 3781184) | | 132. | | Rendell MS, Rajfer J, Wicker PA, Smith MD. Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA. 1999;281:421-6. (PMID: 9952201) | | 133. | | Clement S. Diabetes self-management education. Diabetes Care. 1995;18:1204-14. (PMID: 7587866) | | 134. | | Funnell MM, Haas LB. National standards for diabetes self-management education programs. Diabetes Care. 1995;18:100-16. (PMID: 7698031) | | 135. | | Carney RM, Schechter K, Homa M, Levandoski L, White N, Santiago J. The effects of blood glucose testing versus urine sugar testing on the metabolic control of insulin-dependent diabetic children. Diabetes Care. 1983;6:378-80. (PMID: 6617415) | | 136. | | Schiffrin A, Belmonte M. Multiple daily self-glucose monitoring: its essential role in long-term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections. Diabetes Care. 1982;5:479-84. (PMID: 6765224) | | 137. | | Ziegher O, Kolopp M, Louis J, Musse JP, Patris A, Debry G, et al. Self-monitoring of blood glucose and insulin dose alteration in type 1 diabetes mellitus. Diabetes Res Clin Pract. 1993;21:51-9. (PMID: 8253023) | | 138. | | Litzelman DK, Slemenda CW, Langefeld CD, Hays LM, Welch MA, Bild DE, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. A randomized, controlled trial. Ann Intern Med. 1993;119:36-41. (PMID: 8498761) | | 139. | | Mühlhauser I, Bruckner I, Berger M, Cheta D, Jörgens V, Ionescu-Tîrgoviste C, et al. Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf Study. Diabetologia. 1987;30:681-90. (PMID: 3123298). | | 140. | | Bloomgarden ZT, Karmally W, Metzger MJ, Brothers M, Nechemias C, Bookman J, et al. Randomized, controlled trial of diabetic patient education: improved knowledge without improved metabolic status. Diabetes Care. 1987;10:263-72. (PMID: 3297575) | | 141. | | Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359:1464-76. (PMID: 18779236) | | 142. | | Cooke D, Hurel SJ, Casbard A, Steed L, Walker S, Meredith S, et al. Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA(1c) in insulin-treated diabetes (MITRE Study). Diabet Med. 2009;26:540-7. (PMID: 19646195) | | 143. | | Hellman R, Regan J, Rosen H. Effect of intensive treatment of diabetes of the risk of death or renal failure in NIDDM and IDDM. Diabetes Care. 1997;20:258-64. (PMID: 9051368) | | 144. | | National Society to Prevent Blindness. Vision problems in the US. Facts and Figures; 1980. | | 145. | | Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA. 2007;298:902-16. (PMID: 17712074) | | 146. | | Reiber G, Boyko E, Smith D. Lower extremity foot ulcers and amputations in diabetes. In: Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995:409-428. | | 147. | | Robertson RP, Davis C, Larsen J, Stratta R, Sutherland DE. Pancreas and islet transplantation for patients with diabetes. Diabetes Care. 2000;23:112-6. (PMID: 10857979) | | 148. | | Nathan DM, Singer DE, Hurxthal K, Goodson JD. The clinical information value of the glycosylated hemoglobin assay. N Engl J Med. 1984;310:341-6. (PMID: 6690962) | | 149. | | Kitzmiller JL, Buchanan TA, Kjos S, Combs CA, Ratner RE. Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care. 1996;19:514-41. (PMID: 8732721) | | 150. | | St James PJ, Younger MD, Hamilton BD, Waisbren SE. Unplanned pregnancies in young women with diabetes. An analysis of psychosocial factors. Diabetes Care. 1993;16:1572-8. (PMID: 8299452) | | 151. | | Casele HL, Laifer SA. Factors influencing preconception control of glycemia in diabetic women. Arch Intern Med. 1998;158:1321-4. (PMID: 9645826) | | 152. | | McElvy SS, Miodovnik M, Rosenn B, Khoury JC, Siddiqi T, Dignan PS, et al. A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern Fetal Med. 2000;9:14-20. (PMID: 10757430) | | 153. | | Fuhrmann K, Reiher H, Semmler K, Fischer F, Fischer M, Glöckner E. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care. 1983;6:219-23. (PMID: 6347574) | | 154. | | Diabetes and Pregnancy. American College of Obstetrics and Gynecology Technical Bulletin. Number 200. December 1994. | | 155. | | Eriksson U, Dahlström E, Larsson KS, Hellerström C. Increased incidence of congenital malformations in the offspring of diabetic rats and their prevention by maternal insulin therapy. Diabetes. 1982;31:1-6. (PMID: 6759206) | | 156. | | Miller E, Hare JW, Cloherty JP, Dunn PJ, Gleason RE, Soeldner JS, et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med. 1981;304:1331-4. (PMID: 7012627) | | 157. | | Mills JL, Knopp RH, Simpson JL, Jovanovic-Peterson L, Metzger BE, Holmes LB, et al. Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med. 1988;318:671-6. (PMID: 3344018) | | 158. | | Sibai BM, Caritis S, Hauth J, Lindheimer M, VanDorsten JP, MacPherson C, et al. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 2000;182:364-9. (PMID: 10694338) | | 159. | | Miodovnik M, Rosenn BM, Khoury JC, Grigsby JL, Siddiqi TA. Does pregnancy increase the risk for development and progression of diabetic nephropathy? Am J Obstet Gynecol. 1996;174:1180-9; discussion 1189-91. (PMID: 8623845) | | 160. | | Reece EA, Winn HN, Hayslett JP, Coulehan J, Wan M, Hobbins JC. Does pregnancy alter the rate of progression of diabetic nephropathy? Am J Perinatol. 1990;7:193-7. (PMID: 2331283) | | 161. | | Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol. 1991;78:128-35. (PMID: 2047053) | | 162. | | Jovanovic-Peterson L, Peterson CM, Reed GF, Metzger BE, Mills JL, Knopp RH, et al. Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development–Diabetes in Early Pregnancy Study. Am J Obstet Gynecol. 1991;164:103-11. (PMID: 1986596) | | 163. | | Knopp RH, Magee MS, Walden CE, Bonet B, Benedetti TJ. Prediction of infant birth weight by GDM screening tests. Importance of plasma triglyceride. Diabetes Care. 1992;15:1605-13. (PMID: 1468292) | | 164. | | Raychaudhuri K, Maresh MJ. Glycemic control throughout pregnancy and fetal growth in insulin-dependent diabetes. Obstet Gynecol. 2000;95:190-4. (PMID: 10674578) | | 165. | | Langer O, Levy J, Brustman L, Anyaegbunam A, Merkatz R, Divon M. Glycemic control in gestational diabetes mellitus–how tight is tight enough: small for gestational age versus large for gestational age? Am J Obstet Gynecol. 1989;161:646-53. (PMID: 2782347) | | 166. | | Rizzo T, Metzger BE, Burns WJ, Burns K. Correlations between antepartum maternal metabolism and child intelligence. N Engl J Med. 1991;325:911-6. (PMID: 1881416) | | 167. | | Roversi GD, Gargiulo M, Nicolini U, Ferrazzi E, Pedretti E, Gruft L, et al. Maximal tolerated insulin therapy in gestational diabetes. Diabetes Care. 1980;3:489-94. (PMID: 6993164) | | 168. | | Knopp RH, Magee MS, Raisys V, Benedetti T. Metabolic effects of hypocaloric diets in management of gestational diabetes. Diabetes. 1991;40 Suppl 2:165-71. (PMID: 1748251) | | 169. | | Pedersen H and Molsted-Pedersen L. The hyperglycemia-hyperinsulinism theory and the weight of the newborn baby. In: Rodrigues RR, Vallance-Owen J, eds. Diabetes Excerpta Medica. Amsterdam; 1971:678. | | 170. | | Coustan DR, Reece EA, Sherwin RS, Rudolf MC, Bates SE, Sockin SM, et al. A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies. JAMA. 1986;255:631-6. (PMID: 3511311) | | 171. | | Phelps RL, Sakol P, Metzger BE, Jampol LM, Freinkel N. Changes in diabetic retinopathy during pregnancy. Correlations with regulation of hyperglycemia. Arch Ophthalmol. 1986;104:1806-10. (PMID: 3789980) | | 172. | | Klein BE, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care. 1990;13:34-40. (PMID: 2404715) | | 173. | | Chew EY, Mills JL, Metzger BE, Remaley NA, Jovanovic-Peterson L, Knopp RH, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diabetes Care. 1995;18:631-7. (PMID: 8586000) | | 174. | | Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes Care. 2000;23:1084-91. (PMID: 10937502) | | 175. | | Hod M, Damm P, Kaaja R, Visser GH, Dunne F, Demidova I, et al. Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol. 2008;198:186.e1-7. (PMID: 17905178) | | 176. | | Jovanovic L, Peterson CM. Management of the pregnant, insulin-dependent diabetic woman. Diabetes Care. 1980;3:63-8. (PMID: 6996970) | | 177. | | Cousins L. Pregnancy complications among diabetic women: review 1965-1985. Obstet Gynecol Surv. 1987;42:140-9. (PMID: 3104845) | | 178. | | Landon. Clinical Diabetes, 1990. American College of Obstetrics and Gynecology Technical Bulletin; 1994. | | 179. | | Golde SH, Good-Anderson B, Montoro M, Artal R. Insulin requirements during labor: a reappraisal. Am J Obstet Gynecol. 1982;144:556-9. (PMID: 6753588) | | 180. | | Fraser RB, Bruce C. Amniotic fluid insulin levels identify the fetus at risk of neonatal hypoglycaemia. Diabet Med. 1999;16:568-72. (PMID: 10445832) | | 181. | | Acker DB, Sachs BP, Friedman EA. Risk factors for shoulder dystocia. Obstet Gynecol. 1985;66:762-8. (PMID: 4069477) | | 182. | | Jovanovic L, Peterson CM. Insulin and glucose requirements during the first stage of labor in insulin-dependent diabetic women. Am J Med. 1983;75:607-12. (PMID: 6353916) | | 183. | | Cohen AW, Gabbe SG. Intrapartum management of the diabetic patient. Clin Perinatol. 1981;8:165-72. (PMID: 7237888) | | 184. | | Neubauer SH, Ferris AM, Chase CG, Fanelli J, Thompson CA, Lammi-Keefe CJ, et al. Delayed lactogenesis in women with insulin-dependent diabetes mellitus. Am J Clin Nutr. 1993;58:54-60. (PMID: 8317390) | | 185. | | Gagne MP, Leff EW, Jefferis SC. The breast-feeding experience of women with type 1 diabetes. Health Care Women Int. 1992;13:249-60. (PMID: 1399865) | | 186. | | Virtanen SM, Räsänen L, Ylönen K, Aro A, Clayton D, Langholz B, et al. Early introduction of dairy products associated with increased risk of IDDM in Finnish children. The Childhood in Diabetes in Finland Study Group. Diabetes. 1993;42:1786-90. (PMID: 8243824) | | 187. | | Howey DC, Bowsher RR, Brunelle RL, Woodworth JR. [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin. Diabetes. 1994;43:396-402. (PMID: 8314011) | | 188. | | Mudaliar SR, Lindberg FA, Joyce M, Beerdsen P, Strange P, Lin A, et al. Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care. 1999;22:1501-6. (PMID: 10480516) | | 189. | | Raskin P, Guthrie RA, Leiter L, Riis A, Jovanovic L. Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care. 2000;23:583-8. (PMID: 10834413) | | 190. | | Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes. Diabetes Care. 2000;23:639-43. (PMID: 10834423) | | 191. | | Heinemann L, Linkeschova R, Rave K, Hompesch B, Sedlak M, Heise T. Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care. 2000;23:644-9. (PMID: 10834424) | | 192. | | Colhoun HM; SDRN Epidemiology Group. Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia. 2009;52:1755-65. (PMID: 19603149) | | 193. | | Jonasson JM, Ljung R, Talbäck M, Haglund B, Gudbjörnsdòttir S, Steineck G. Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden. Diabetologia. 2009;52:1745-54. (PMID: 19588120) | | 194. | | Hemkens LG, Grouven U, Bender R, Günster C, Gutschmidt S, Selke GW, et al. Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia. 2009;52:1732-44. (PMID: 19565214) | | 195. | | Currie CJ, Poole CD, Gale EA. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 2009;52:1766-77. (PMID: 19572116) | | 196. | | Simon D. Diabetes treatment with insulin glargine and risk of malignancy: methodological pitfalls and ethical issues. Diabetologia. 2010;53:204-5. (PMID: 19859691) | | 197. | | Nagel JM, Mansmann U, Wegscheider K, Röhmel J. Insulin resistance and increased risk for malignant neoplasms: confounding of the data on insulin glargine. Diabetologia. 2010;53:206-8. (PMID: 19774358) | | 198. | | Rosenstock J, Fonseca V, McGill JB, Riddle M, Hallé JP, Hramiak I, et al. Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study. Diabetologia. 2009;52:1971-3. (PMID: 19609501) | | 199. | | Smith U, Gale EA. Does diabetes therapy influence the risk of cancer? Diabetologia. 2009;52:1699-708. (PMID: 19597799) | | 200. | | Soran H, Younis N. Insulin detemir: a new basal insulin analogue. Diabetes Obes Metab. 2006;8:26-30. (PMID: 16367879) | | 201. | | Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care. 1995;18:517-22. (PMID: 7497862) | | 202. | | Cryer PE. Hierarchy of physiological responses to hypoglycemia: relevance to clinical hypoglycemia in type 1 (insulin dependent) diabetes mellitus. Horm Metab Res. 1997;29:92-6. (PMID: 9137976) | | 203. | | Cryer PE. Hypoglycemia begets hypoglycemia in IDDM. Diabetes. 1993;42:1691-3. (PMID: 8243813) | | 204. | | Mokan M, Mitrakou A, Veneman T, Ryan C, Korytkowski M, Cryer P, et al. Hypoglycemia unawareness in IDDM. Diabetes Care. 1994;17:1397-403. (PMID: 7882808) | | New References of Interest | | 205. | | Shurraw S, Hemmelgarn B, Lin M, Majumdar SR, Klarenbach S, Manns B, et al.; Alberta Kidney Disease Network. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med. 2011;171:1920-7. (PMID: 22123800) | | 206. | | de Boer IH, Sun W, Cleary PA, Lachin JM, Molitch ME, Steffes MW, et al.; DCCT/EDIC Research Group. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med. 2011;365:2366-76. (PMID: 22077236) | | 207. | | Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane WV, Vigersky RA, et al. Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96:2968-79. (PMID: 21976745) | | 208. | | Paynter NP, Mazer NA, Pradhan AD, Gaziano JM, Ridker PM, Cook NR. Cardiovascular Risk Prediction in Diabetic Men and Women Using Hemoglobin A1c vs Diabetes as a High-Risk Equivalent. Arch Intern Med. 2011;171:1712-8. (PMID: 21788538) | | 209. | | Morrison F, Shubina M, Turchin A. Encounter frequency and serum glucose level, blood pressure, and cholesterol level control in patients with diabetes mellitus. Arch Intern Med. 2011;171:1542-50. (PMID: 21949161) | | 210. | | Harjutsalo V, Forsblom C, Groop PH. Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study. BMJ. 2011;343:d5364. (PMID: 21903695) | | 211. | | Pape GA, Hunt JS, Butler KL, Siemienczuk J, Leblanc BH, Gillanders W, et al. Team-based care approach to cholesterol management in diabetes mellitus: 2-year cluster randomized controlled trial. Arch Intern Med. 2011;171:1480-6. (PMID: 21911633) | | 212. | | Sherry N, Hagopian W, Ludvigsson J, Jain SM, Wahlen J, Ferry RJ, et al.; Protégé Trial Investigators. Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial. Lancet. 2011;378:487-97. (PMID: 21719095) | | 213. | | Orban T, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, et al.; Type 1 Diabetes TrialNet Abatacept Study Group. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;378:412-9. (PMID: 21719096) | | 214. | | Wherrett DK, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, et al.; Type 1 Diabetes TrialNet GAD Study Group. Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial. Lancet. 2011;378:319-27. (PMID: 21714999) | | 215. | | Usher-Smith JA, Thompson MJ, Sharp SJ, Walter FM. Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. BMJ. 2011;343:d4092. (PMID: 21737470) | | 216. | | Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ. 2011;343:d3805. (PMID: 21737469) | | 217. | | Lind M, Bounias I, Olsson M, Gudbjörnsdottir S, Svensson AM, Rosengren A. Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study. Lancet. 2011;378:140-6. (PMID: 21705065) | | 218. | | de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011;305:2532-9. (PMID: 21693741) | | 219. | | Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D, et al. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ. 2011;342:d1855. (PMID: 21493665) | | 220. | | Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, et al.; American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2011;76:1758-65. (PMID: 21482920) | | 221. | | Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N. Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med. 2011;171:404-10. (PMID: 21403036) | | 222. | | de Boer IH, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, et al.; for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Long-term Renal Outcomes of Patients With Type 1 Diabetes Mellitus and Microalbuminuria: An Analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Cohort. Arch Intern Med. 2011;171:412-420. (PMID: 21403038) | | 223. | | Haller H, Ito S, Izzo JL, Januszewicz A, Katayama S, Menne J, et al.; ROADMAP Trial Investigators. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med. 2011;364:907-17. (PMID: 21388309) | | 224. | | Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al.; Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364:829-41. (PMID: 21366474) | | 225. | | Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ. 2011;342:d35. (PMID: 21292721) | | 226. | | Qaseem A, Humphrey LL, Chou R, Snow V, Shekelle P; for the Clinical Guidelines Committee of the American College of Physicians. Use of Intensive Insulin Therapy for the Management of Glycemic Control in Hospitalized Patients: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2011;154:260-267. (PMID: 21320941) | | 227. | | Kansagara D, Fu R, Freeman M, Wolf F, Helfand M. Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med. 2011;154:268-82. (PMID: 21320942) | | 228. | | Barzilay JI, Gao P, O'Donnell M, Mann JF, Anderson C, Fagard R, et al.; ONTARGET and TRANSCEND Investigators. Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies. Arch Intern Med. 2011;171:142-50. (PMID: 21263104) | | 229. | | Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304:649-56. (PMID: 20699456) | | 230. | | Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, et al.; STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363:311-20. (PMID: 20587585) | | 231. | | Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124-36. (PMID: 20580421) | | 232. | | Cooper-DeHoff RM, Gong Y, Handberg EM, Bavry AA, Denardo SJ, Bakris GL, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA. 2010;304:61-8. (PMID: 20606150) | | 233. | | Timbie JW, Hayward RA, Vijan S. Variation in the net benefit of aggressive cardiovascular risk factor control across the US population of patients with diabetes mellitus. Arch Intern Med. 2010;170:1037-44. (PMID: 20585069) | | 234. | | Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al.; Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215-22. (PMID: 20609967) | | 235. | | O'Hare AM, Hailpern SM, Pavkov ME, Rios-Burrows N, Gupta I, Maynard C, et al. Prognostic implications of the urinary albumin to creatinine ratio in veterans of different ages with diabetes. Arch Intern Med. 2010;170:930-6. (PMID: 20548004) | | 236. | | Bao Y, Ma X, Li H, Zhou M, Hu C, Wu H, et al. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ. 2010;340:c2249. (PMID: 20478961) | | 237. | | House AA, Eliasziw M, Cattran DC, Churchill DN, Oliver MJ, Fine A, et al. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA. 2010;303:1603-9. (PMID: 20424250) | | 238. | | Peyrot M, Rubin RR, Kruger DF, Travis LB. Correlates of insulin injection omission. Diabetes Care. 2010;33:240-5. (PMID: 20103556) | | 239. | | Meacham LR, Sklar CA, Li S, Liu Q, Gimpel N, Yasui Y, et al. Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study. Arch Intern Med. 2009;169:1381-8. (PMID: 19667301) | | 240. | | De Berardis G, Sacco M, Strippoli GF, Pellegrini F, Graziano G, Tognoni G, et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ. 2009;339:b4531. (PMID: 19897665) | | FAQs |
|
Abd A. Tahrani, MD, MRCP, editorial consultant, received a grant from the UK Novo Nordisk Research Foundation. Maureen D. Passaro, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Robert E. Ratner, MD, is a consultant for Amylin Pharmaceuticals, AstraZeneca, GlaxoSmithKline, Lifescan, Inc., NovoNordisk, Sanofi-Aventis, Takeda, owns stocks in Merck, Johnson & Johnson, Abbott, received grants from Amylin, AstraZeneca, Bayhill Therapeutics, Boehringer Ingelheim, Conjuchem, Inc., Eil Lilly, GlaxoSmithKline, Merck, NovoNordisk, Pfizer, Sanofi-Aventis, Takeda.
Deborah Korenstein, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Richard B. Lynn, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. |
Diabetes Mellitus, Type 1
